-
Bharat Biotech expects EUA from WHO for Covaxin in July- September
Bharat Biotech said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others
-
Panacea Biotec hits upper circuit on commencing production of Sputnik V vaccine
The first batch produced at Panacea Biotec's facilities at Baddi will be shipped to the Gamaleya Center for quality control.
-
India logs 13% fall in new Covid-19 cases in week; still highest globally: WHO
As per the WHO estimates, cumulative cases in India currently stand at about 24.68 million and total deaths are at about 270,284
-
WHO says India COVID variant found in 44 countries, of global concern
According to the WHO, B.1.617 sub-lineages appear to have higher rates of transmission, including observed rapid increases in prevalence in multiple c
-
Variant accelerating India’s Covid explosion: WHO top scientist
Soumya Swaminathan, a paediatrician and clinical scientist, said the B.1.617 variant of Covid-19, which was first detected in India last October, was
-
WHO panel OKs emergency use of China’s Sinopharm vaccine
The decision by a WHO technical advisory group opens the possibility that the Sinopharm vaccine could be included into the UN-backed COVAX program in
-
WHO chief calls growth in virus cases ”worrying”
WHO Director-General Tedros Adhanom Ghebreyesus said the number of new cases is approaching the highest rate of infection that we have seen so far in
-
WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months
The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date
-
India to UN: We have supplied more vaccines globally than having vaccinated our own people
India has been at the forefront of the global fight against COVID-19
-
WHO reiterates call to continue use of AstraZeneca’s COVID-19 vaccine
The WHO's Global Advisory Committee on Vaccine Safety is due to publish the conclusions of its assessment of the safety of AstraZeneca's vaccine on Ma
